NY Times

A F.D.A. panel is set to discuss Pfizer shots for children 5 to 11 and boosters for Moderna and J. & J. recipients.

The timing of the meetings indicates that the agency plans to move quickly to decide whether to authorize both the booster and pediatric doses, but only after it hears recommendations from the advisory committee.


About the author


Leave a Comment